Successful treatment of massive pulmonary embolism in a pregnant woman, with low-dose, slow infusion of tissue plasminogen activator

Turk Kardiyoloji Dernegi Arsivi

Volumn 38, Issue 1, 2010, Pages 32-34

  Biteker, Murat ^a   Duran, Nilüfer Ekşi ^a   Özkan, Mehmet ^a  

^a Kartal Kosuyolu Yuksek Ihtisas Egitim ve Arastirma Hastanesi Kardiyoloji Klinigi   (Turkey)

Author keywords

Pregnancy complications, cardiovascular; Pulmonary embolism drug therapy; Thrombolytic therapy; Tissue plasminogen activator therapeutic use

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 8; FIBRINOGEN; HEPARIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PROTHROMBIN; TISSUE PLASMINOGEN ACTIVATOR; WARFARIN;

ADULT; ARTICLE; CASE REPORT; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HUMAN; INTRACARDIAC THROMBOSIS; LOW DRUG DOSE; LUNG EMBOLISM; PREGNANT WOMAN; SINUS TACHYCARDIA; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT RESPONSE;

CESAREAN SECTION; ECHOCARDIOGRAPHY; FEMALE; FEMORAL VEIN; HEART MURMURS; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS; PULMONARY EMBOLISM; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER; VENOUS THROMBOSIS; YOUNG ADULT;

EID: 77952318298     PISSN: 10165169     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Clark P, Brennand J, Conkie JA, McCall F, Greer IA, Walker ID. Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy. Thromb Haemost 1998;79:1166-1170 (Pubitemid 28297166)
2. Walker MC, Garner PR, Keely EJ. Thrombosis in pregnancy: a review. J Soc Obstet Gynaecol Can 1998;20:943-952
3. Grandone E, Margaglione M, Colaizzo D, D'Andrea G, Cappucci G, Brancaccio V, et al. Genetic susceptibility to pregnancy-related venous thromboembolism: roles of factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations. Am J Obstet Gynecol 1998;179:1324-1328 (Pubitemid 28533795)
4. Lindqvist PG, Svensson PJ, Marsaál K, Grennert L, Luterkort M, Dahlbäck B. Activated protein C resistance (FV:Q506) and pregnancy. Thromb Haemost 1999;81:532-537
5. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999;353:1386-1389 (Pubitemid 29192409)
6. Wan S, Quinlan DJ, Agnelli G, Eikelboom JW. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials. Circulation 2004;110:744-749
7. Flossdorf T, Breulmann M, Hopf HB. Successful treatment of massive pulmonary embolism with recombinant tissue type plasminogen activator (rt-PA) in a pregnant woman with intact gravidity and preterm labour. Intensive Care Med 1990;16:454-456
8. Kramer WB, Belfort M, Saade GR, Surani S, Moise KJ Jr. Successful urokinase treatment of massive pulmonary embolism in pregnancy. Obstet Gynecol 1995;86:660-662
9. Biteker M, Duran NE, Gündüz S, Özkan M. Treatment of pulmonary embolism with low-dose prolonged infusion of tissue-type plasminogen activator in an 85-year-old woman. J Am Geriatr Soc 2009;57:745-746
10. Biteker M, Duran NE, Gündüz S, Kaya H, Kaynak E, Çevik C, et al. Comparing different intravenous thrombolytic treatment regimens in patients with prosthetic heart valve thrombosis under the guidance of serial transesophageal echocardiography: a 15-year study in a single center (TROIA Trial). Circulation 2008;118:S932.